Gossamer Bio (GOSS) R&D/CAPEX US GAAP (year values)

2018 2019 2020 2021 2022   LTM ? CAGR 5 years ?
R&D/CAPEX, % 260.6% 2 184% 646.4% 10 504% 35 983%   56.6%  
Changes by years, y/y, % +1 923pp -1 538pp +9 857pp +25 479pp     +242.8%

Gossamer Bio. R&D/CAPEX, %

Gossamer Bio. R&D/CAPEX, changes, pp

Gossamer Bio (GOSS) R&D/CAPEX US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
R&D/CAPEX, % 104 000% 49 463% 29.9% 30.0%   56.6%
Changes by years, y/y, % +7 241pp +13 986pp -251 967pp -242 030pp -103 970pp    
Changes by quarters, q/q, % -138 060pp -54 537pp -49 463pp +0pp    

Gossamer Bio. R&D/CAPEX, %

Gossamer Bio. R&D/CAPEX, changes, pp

Gossamer Bio. R&D/CAPEX, changes, pp